CASI Pharmaceuticals (CASIF) Goodwill & Intangibles (2020 - 2025)

CASI Pharmaceuticals has reported Goodwill & Intangibles for 6 years, with the latest figure at $221000.0 in Q4 2025.

• For the quarter ending Q4 2025, Goodwill & Intangibles rose 38.99% year-over-year to $221000.0; the trailing twelve-month figure through Dec 2025 stood at $221000.0 (up 38.99% YoY), and the FY2025 full-year result was $221000.0, up 38.99% from the prior year.
• Goodwill & Intangibles for Q4 2025 stood at $221000.0, down from $224000.0 in the prior quarter.
• The five-year high for Goodwill & Intangibles was $1.4 billion in Q2 2024, with the low at $159000.0 in Q4 2024.
• Historically, Goodwill & Intangibles has averaged $195.1 million across 5 years, with a median of $1.6 million in 2024.
• The largest YoY upside for Goodwill & Intangibles was 14247.29% in 2025 against a maximum downside of 99.98% in 2025.
• CASI Pharmaceuticals' Goodwill & Intangibles stood at $12.2 million in 2021, then tumbled by 91.29% to $1.1 million in 2022, then soared by 94.17% to $2.1 million in 2023, then sank by 92.3% to $159000.0 in 2024, then jumped by 38.99% to $221000.0 in 2025.
• The last three Goodwill & Intangibles figures came in at $221000.0 (Q4 2025), $224000.0 (Q3 2025), and $230000.0 (Q2 2025), per Business Quant data.